AFT Pharmaceuticals has opened a new front in its eye drop portfolio, with the introduction of a preservative-free product called Ocuzo for bacterial eye infections.
Read More
Honouring the preservative-free mantra
Ophthalmic products are a significant contributor to AFT Pharmaceuticals’ bottom line. Combined with an unmet need for preservative-free products, the company is highly motivated to expand its pipeline, says CEO and founder DR HARTLEY ATKINSON.
Read More
Read More
NovaTears + Omega-3 effective against evaporative dry eye – study
Australasian drug company AFT Pharmaceuticals has announced results from a post-market study of licensed dry eye therapy NovaTears + Omega-3, stating it is a significantly effective treatment for the evaporative form of the disease.
Read More
Read More
Finding a niche with preservative-free eye drops
In the space of 23 years AFT Pharmaceuticals has gone from a home-based business to a multinational company. Its eyecare business is also experiencing remarkable growth, and more therapies are in the pipeline, including one for glaucoma.
Read More
Omega-3 dry eye drop arrives in Australia
AFT Pharmaceuticals has officially introduced NovaTears + Omega-3 eye drops in Australia, and provided new details about the formulation.
Read More
Read More